A Smart Investment: Cell And Gene Feasibility That Prepares You For Clinical Success

The success of any gene therapy program depends on a deep understanding of the unique characteristics of the Gene of Interest (GOI). Before advancing to large-scale production, it is crucial to verify that your GOI can integrate smoothly into a viral vector manufacturing platform. Neglecting this vital step can lead to unforeseen challenges that not only disrupt development timelines but also result in significant, often avoidable costs.

In this blog, we will delve into why investing in a comprehensive feasibility program for GOI testing is not just beneficial, but absolutely essential for cell and gene therapy companies. By conducting thorough testing at the early stages, companies can mitigate risks, streamline production processes, and ultimately accelerate the path to successful therapeutic development.